Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KLA CORPKLAC · Entity 2838 | Director | November 06, 2024 | November 08, 2024 |
| One Equity Partners Open Water I Corp.OEPW · Entity 143451 | Director | January 21, 2021 | January 22, 2021 |
| RAMBUS INCRMBS · Entity 3575 | Director | June 02, 2026 | June 03, 2026 |
| TAKEDA PHARMACEUTICAL CO LTDTAK · Entity 2662 | Director | March 18, 2026 | March 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KLA CORP
Report date November 06, 2024 · Filed November 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,766 |
Reported balance
After 2024-11-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-11-06 · Grant · Acquired 350 · Balance 14,766 F1: On November 6, 2024, the Reporting Person received an automatic grant of restricted stock units ("RSUs") for 350 shares of KLA common stock. The RSUs vest on the earliest to occur of (i) November 6, 2025, (ii) immediately prior to the next annual meeting of stockholders, and (iii) ten days prior to a change of control of KLA. F2: The number of shares of KLA common stock includes 350 shares issuable upon vesting of RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 6, 2024, the Reporting Person received an automatic grant of restricted stock units ("RSUs") for 350 shares of KLA common stock. The RSUs vest on the earliest to occur of (i) November 6, 2025, (ii) immediately prior to the next annual meeting of stockholders, and (iii) ten days prior to a change of control of KLA.
F2: The number of shares of KLA common stock includes 350 shares issuable upon vesting of RSUs.
One Equity Partners Open Water I Corp.
Report date January 21, 2021 · Filed January 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B common stockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-01-21 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: As described in the issuer's registration statement on Form S-1 (File No. 333- 251925) under the heading "Description of Securities--Founder Shares", the Class B common stock, par value $0.0001, will automatically convert into Class A common stock, par value $0.0001, of the issuer at the time of the issuer's initial business combination on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: As described in the issuer's registration statement on Form S-1 (File No. 333- 251925) under the heading "Description of Securities--Founder Shares", the Class B common stock, par value $0.0001, will automatically convert into Class A common stock, par value $0.0001, of the issuer at the time of the issuer's initial business combination on a one-for-one basis, subject to adjustment for share splits, share capitalizations, reorganizations, recapitalizations and the like, and certain anti-dilution rights and have no expiration date.
RAMBUS INC
Report date June 02, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 49,519 |
Ending reported balance
After 2026-06-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-02 · Sale · Disposed 5,000 · Balance 54,519 F1: All shares sold at an exact price of $163.00. Row 2 · 2026-06-02 · Sale · Disposed 5,000 · Balance 49,519 F2: All shares sold at an exact price of $158.00. |
Filing footnotes · ownership attribution and instrument terms
F1: All shares sold at an exact price of $163.00.
F2: All shares sold at an exact price of $158.00.
TAKEDA PHARMACEUTICAL CO LTD
Report date March 18, 2026 · Filed March 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| American Depositary SharesSEC Table I · non-derivative | Direct | 7,600 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,600 |
| Ordinary SharesSEC Table I · non-derivative | Direct | 17,800 |
Reported balance
Holding disclosure · report date 2026-03-18 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 17,800 F1: Includes 12,800 restricted stock units (RSUs). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 shares), June 1, 2027 (3,400 shares), June 1, 2028 (3,200 shares) and upon conclusion of the director's board service (3,100 shares). |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2026-06-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2027-06-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2028-06-01 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance Not disclosed F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
| Tax Obligation AwardSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-18 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance Not disclosed F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. F3: Vests upon conclusion of the director's service on the board. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 12,800 restricted stock units (RSUs). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 shares), June 1, 2027 (3,400 shares), June 1, 2028 (3,200 shares) and upon conclusion of the director's board service (3,100 shares).
F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
F3: Vests upon conclusion of the director's service on the board.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
InvenSense Inc
Report date May 18, 2017 · Filed May 22, 2017
Section 16 reporting ended · disclosed 2017-05-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-05-18 transaction · row 1
1 source rowRow 1 · 2017-05-18 · Disposition to issuer · Disposed 22,705 · Balance 0 F1: Disposed of in connection with the acquisition of the Issuer by TDK Corporation (the "Merger") pursuant to the Agreement and Plan of Merger, dated as of December 21, 2016, by and among the Issuer, TDK Corporation and TDK Sensor Solutions Corporation, (the "Merger Agreement"), whereby each share of Issuer common stock ("Issuer Common Stock") other than certain shares owned by the Issuer, TDK Corporation and their respective subsidiaries and shares subject to appraisal rights, was automatically cancelled and converted into the right to receive $13.00 in cash, without interest (the "Merger Consideration"). |
| Restricted Stock Unit (RSU)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-05-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-05-18 · Disposition to issuer · Disposed 15,638 · Balance 0 F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive at settlement one share of Invensense common stock at no cost. F4: Disposed of pursuant to the Merger Agreement, whereby each vested restricted stock unit of Issuer Common Stock ("RSU") was cancelled in exchange for the right to receive a cash payment equal to the product of the Merger Consideration multiplied by the total number of shares subject to the vested RSU. Pursuant to the terms of the applicable RSU award agreement, 100% of the unvested RSUs held by the Reporting Person became fully vested upon the change in control of the Issuer effected by the Merger. F3: Subject to the Reporting Person's continuing service to the corporation and the provisions in the Invensense's standard form of RSU award agreement, the shares will vest on December 31, 2017. Shares will be delivered to the reporting person on each vest date; provided, however, that settlement of each RSU will be deferred to the first permissible trading day for the corporation's common stock, if later than the applicable vesting date, but no later than March 15th of the year following the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of in connection with the acquisition of the Issuer by TDK Corporation (the "Merger") pursuant to the Agreement and Plan of Merger, dated as of December 21, 2016, by and among the Issuer, TDK Corporation and TDK Sensor Solutions Corporation, (the "Merger Agreement"), whereby each share of Issuer common stock ("Issuer Common Stock") other than certain shares owned by the Issuer, TDK Corporation and their respective subsidiaries and shares subject to appraisal rights, was automatically cancelled and converted into the right to receive $13.00 in cash, without interest (the "Merger Consideration").
F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive at settlement one share of Invensense common stock at no cost.
F3: Subject to the Reporting Person's continuing service to the corporation and the provisions in the Invensense's standard form of RSU award agreement, the shares will vest on December 31, 2017. Shares will be delivered to the reporting person on each vest date; provided, however, that settlement of each RSU will be deferred to the first permissible trading day for the corporation's common stock, if later than the applicable vesting date, but no later than March 15th of the year following the vesting date.
F4: Disposed of pursuant to the Merger Agreement, whereby each vested restricted stock unit of Issuer Common Stock ("RSU") was cancelled in exchange for the right to receive a cash payment equal to the product of the Merger Consideration multiplied by the total number of shares subject to the vested RSU. Pursuant to the terms of the applicable RSU award agreement, 100% of the unvested RSUs held by the Reporting Person became fully vested upon the change in control of the Issuer effected by the Merger.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 06, 2013 Filed Nov 7, 2013 00:13 UTC | KLA CORP KLAC · Entity 2838 | GrantCommon Stock - Restricted Stock Units | 1,856 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-13-057394 · rrd393727.xml · nonDerivative · entry 1 Higashi Emiko · CIK 0001318086 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,414 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of KLA-Tencor common stock. F2 · shares: Represents a grant of RSUs that, pursuant to KLA-Tencor's outside director compensation program, was automatically granted to the Reporting Person on the date of KLA-Tencor's annual meeting of stockholders with respect to the Reporting Person's service on the Board of Directors for the upcoming year. The RSUs will fully vest one year from date of grant and will be deliverable on such date. Read SEC document |
| November 07, 2012 Filed Nov 9, 2012 21:34 UTC | KLA CORP KLAC · Entity 2838 | GrantCommon Stock - Restricted Stock Units | 2,558 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-12-057972 · rrd359794.xml · nonDerivative · entry 1 Higashi Emiko · CIK 0001318086 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,558 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of KLA-Tencor common stock. F2 · shares: The RSUs will fully vest one year from the date of grant and will be deliverable on such date. Read SEC document |
| November 03, 2011 Filed Nov 4, 2011 20:47 UTC | KLA CORP KLAC · Entity 2838 | GrantCommon Stock - Restricted Stock Units | 2,539 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-11-054876 · rrd324853.xml · nonDerivative · entry 1 Higashi Emiko · CIK 0001318086 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,539 F1 · security: Each restricted stock unit ("RSU") represents a contingent right to receive one share of KLA-Tencor common stock. F2 · shares: The restricted stock units will fully vest one year from date of grant and will be deliverable on such date. Read SEC document |
| November 03, 2010 Filed Nov 4, 2010 20:35 UTC | KLA CORP KLAC · Entity 2838 | GrantCommon Stock - Restricted Stock Units | 2,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-10-053495 · rrd290098.xml · nonDerivative · entry 1 Higashi Emiko · CIK 0001318086 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,772 F1 · security: Each restricted stock unit represents a contingent right to receive one share of KLA-Tencor common stock. F2 · shares: The restricted stock units will fully vest one year from date of grant and will be deliverable on such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.